Diabetes Obes Metab 22(6):938946
Ava Helen Pauling Professor Emeritus, Linus Pauling Institute Professor Emeritus, College Health Oregon State University Copyright 2000-2026 Linus Pauling Institute Figure Alternative Text Figure 1
The alcohol and semaglutide interaction is also relevant here, since alcohol use affects liver enzymes independently and adds a layer of complexity to interpreting ALT and AST changes
Whether youre managing a chronic condition, focusing on preventive care, or aiming to optimize your health, Jarred Mait, MD provides exceptional attention and support
Both are available in standard and microdosing formats
Key Industry Developments In March 2026 , China approved Pfizers once-weekly injectable GLP-1 weight-loss drug Xianweiying (ecnoglutide) for long-term weight management in overweight or obese adults, strengthening Pfizers position in the rapidly expanding obesity therapeutics market